These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15613055)

  • 1. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Favaloro EJ
    J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
    [No Abstract]   [Full Text] [Related]  

  • 2. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Hajdenberg J
    J Thromb Haemost; 2004 Dec; 2(12):2282-3; author reply 2283-5. PubMed ID: 15613056
    [No Abstract]   [Full Text] [Related]  

  • 4. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
    Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
    Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
    Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
    Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?
    Cattaneo M
    J Thromb Haemost; 2004 Jun; 2(6):890-1. PubMed ID: 15140123
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporary platelet function testing.
    Favaloro EJ; Lippi G; Franchini M
    Clin Chem Lab Med; 2010 May; 48(5):579-98. PubMed ID: 20148722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function.
    Kerényi A; Schlammadinger A; Ajzner E; Szegedi I; Kiss C; Pap Z; Boda Z; Muszbek L
    Thromb Res; 1999 Dec; 96(6):487-92. PubMed ID: 10632473
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
    Pereira J; Quiroga T; Mezzano D
    Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common bleeding problems.
    Moake JL; Funicella T
    Clin Symp; 1983; 35(3):1-32. PubMed ID: 6336273
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
    Quiroga T; Pérez M; Rodríguez S; Muñoz B; Aranda E; Morales M; Verdugo P; Pereira J; Mezzano D
    Rev Med Chil; 1997 Apr; 125(4):409-18. PubMed ID: 9460281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function: a rebuttal.
    Kratzer MA
    J Thromb Haemost; 2006 Aug; 4(8):1845-6. PubMed ID: 16879234
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?
    Favaloro EJ
    Haematologica; 2007 Mar; 92(3):292-6. PubMed ID: 17339176
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Broadsheet 122: August 1989. Platelet function testing.
    Hutton RA; Ludlam CA
    J Clin Pathol; 1989 Aug; 42(8):858-64. PubMed ID: 2768525
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic approach to mild bleeding disorders.
    Bachmann F
    Semin Hematol; 1980 Oct; 17(4):292-305. PubMed ID: 7003721
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of the PFA-100.
    Favaloro EJ
    Curr Opin Hematol; 2002 Sep; 9(5):407-15. PubMed ID: 12172459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.